New papers on Cancer biology
80 new papers on cancer biology in the last 7 days, within Biology. These are the 50 Pipette rates most worth reading, with the main result in the authors' own words.
The best of the week
Evolutionary dynamics in the years preceding acute myeloid leukaemia
Using deep duplex sequencing and evolutionary theory, we quantify the acquisition ages and fitness effects of the key driver events in acute myeloid leukaemia development.
Peer-reviewed journalSynthetic Hibernation Suppresses Osteosarcoma Growth and Protects Normal Tissue from Radiation
Together, these findings support synthetic hibernation as a strategy to restrain tumor growth and mitigate normal-tissue radiation injury without compromising tumor control.
PreprintReal-world useFunctionally divergent RHOA mutations drive peripheral T cell lymphoma development by engaging a common neomorphic pathway
Here we show that all PTCL-associated RHOA mutants acquire a non-canonical VAV1-like activity that activates the transcription factor NFAT.
Peer-reviewed journalReal-world useProgrammable Imaging of Locus-Specific DNA Repair Dynamics Reveals Chromatin-Controlled Therapy Resistance in Cancer
Together, our findings reveal chromatin accessibility as a key determinant of DSB repair dynamics and support a mechanistic link and actionable connection between chromatin state, DNA repair, and immunotherapy response.
PreprintReal-world useTryptophan catabolism drives AhR-dependent macropinocytosis and tumorigenesis in tuberous sclerosis complex
Collectively, our data identify a Trp-kynurenine-AhR axis that supports macropinocytosis in TSC2-deficient cells, and suggest AhR antagonists as a novel therapeutic approach for the treatment of TSC and LAM.
PreprintReal-world useThe p38α MAPK–MK2 axis drives chemotherapy-mediated nuclear actin remodeling to promote ovarian cancer progression
Mechanistically, the p38α MAPK–MK2 signaling pathway promotes formin-mediated nuclear F-actin assembly in response to chemotherapy.
Peer-reviewed journalReal-world useTet2-Clonal Hematopoiesis Promotes Whereas Dnmt3a-CH Inhibits Breast Cancer Progression During Aging
Using inducible murine models of Dnmt3a- or Tet2-mutant CHIP combined with orthotopic syngeneic breast cancer models, we demonstrate that upon aging Dnmt3a-mutant CHIP prevents whereas Tet2-mutant CHIP drives breast cancer progression.
PreprintThe genetic landscape of canine tumors: Insights from the Canine Cancer Genome Atlas (CCGA)
Selection analyses identified 39 cancer drivers, including recurrent TP53 , PIK3CA , PTEN , SETD2 , MAP3K14 , and FAT4 alterations; copy number events included MYC amplifications and PTEN deletions.
Peer-reviewed journalS100A4 Is a Targetable Regulator of Immune Suppression in Glioblastoma
Here, we use mouse models of GBM to identify S100A4 as an actionable regulator of immune suppression and demonstrate that its inhibition converts GBM into an immunotherapy-responsive state.
PreprintBold claims, read criticallyReal-world useMultiomic analysis of a pleural mesothelioma organoid biobank defines gene dependencies and therapeutic vulnerabilities
This functional map of shared and genotype-specific dependencies establishes patient-derived organoids as a scalable platform for precision therapeutic discovery in pleural mesothelioma
PreprintDecomposing tissue-of-origin aging clocks reveals composite aging states across cancers
Across breast and five other cancers, this decomposition reveals composite aging states in which youth-like deviations in proliferative pathways coexist with older-like deviations in damage-response and signaling pathways.
PreprintLight power density governs local and systemic responses to photodynamic therapy
Here, we show that light power density (mW/cm2), which is often treated as a mere technical parameter, determines whether PDT suppresses distant, unirradiated tumors.
PreprintReal-world useLow-order assemblies drive oncogenic RTK fusion signalling without condensation
Our results suggest that low-order multimerization is sufficient to drive fusion phosphorylation, which is necessary and sufficient to trigger downstream oncogenic signalling.
Peer-reviewed journalNRF2-driven thiol metabolism creates a selective vulnerability to selenite
Here we show that NRF2-driven metabolic reprogramming creates a selective vulnerability to selenite.
PreprintReal-world useA genetically engineered porcine model of pancreatic ductal adenocarcinoma captures the biological complexity of the human disease.
Together, this genetically engineered porcine PDAC model captures early molecular, cellular, and microenvironmental features of pancreatic tumorigenesis and provides a translational platform to study disease initiation, tumour heterogeneity, immune interactions, and therapeutic response beyond the constraints of rodent models.
PreprintHPV Oncogenes rewire DNA crosslink repair to create a PRIMPOL-dependent therapeutic vulnerability
Our findings show that HPV oncogenes rewire the response to crosslink-induced replication stress and identify RAD51 filament dynamics as a therapeutic vulnerability in HPV+ HNSCC.
PreprintReal-world useFasL blockade suppresses liver metastasis and prolongs survival in small-cell lung cancer
Together, our findings identify Fas-FasL signalling as an unexpected regulator of SCLC metastatic progression and establish FasL blockade as a promising therapeutic strategy capable of prolonging survival in established disease beyond conventional immune checkpoint inhibition.
PreprintReal-world useA cellular atlas of the preinvasive breast cancer microenvironment
Our data shows remodeling of fibroblasts, vascular and basal cells that encircle the DCIS regions and immunosuppressive ducts that support the growth of the preinvasive cancer cells.
Peer-reviewed journalKDM3B enforces a non-mutational ErbB signaling state that sustains cholangiocarcinoma
These findings establish KDM3B as a non-mutational epigenetic activator of ErbB-driven signaling, reshaping the tumor ecosystem, and defining the KDM3B-ErbB axis as a vulnerability in CCA.
PreprintReal-world useSelectively disrupting lysine acetyltransferase p300 and ZEB1 interaction prevents tumor progression while enhancing antitumor immunity
Collectively, our data demonstrate that selective disrupting of p300 and ZEB1 interaction effectively prevents tumor progression and may offer a promising therapeutic strategy for p300–ZEB1 axis-driven malignancies.
Peer-reviewed journalReal-world useCCR8⁺ regulatory T cell depletion overcomes immune checkpoint blockade resistance in BRCA2-deficient prostate cancer
However, depletion of CCR8 regulatory T cells overcame resistance to checkpoint blockade.
PreprintN- and T-genes framework for pathway deregulation: Taxonomy, progression, and protection in cancer
The framework eliminates dilution by non-nformative genes, quantifies pathway deregulation sample by sample, and unifies tumor taxonomy with a molecular indicator of progression.
PreprintExtracellular matrix spatial ecosystems define stem-like niches and predict post-recurrence survival in glioblastomas
Focusing on whole matrisome gene expression, we identified three reproducible and spatially coherent ECM transcriptional programs, termed Homeostatic, Stress, and Fibrous, that were associated with specific microenvironmental functions and neoplastic cell states, with the strongest association noted between Homeostatic ECM and neoplastic quiescent stem cell-like (QSC) niches.
PreprintFish Metastasis Atlas for the Systematic Analysis of Organ-Specific Dissemination of Cancer
Here, we introduce an in vivo zebrafish model coupled with a data driven computational framework to systematically map and compare patterns of cancer dissemination.
PreprintBold claims, read criticallyA Three-Axis Framework for Therapy Prioritization in MBD4-Deficient Tumors: De-confounded Synthetic Lethality Modeling, Replication-Stress Pharmacology, and PARP1 Trapping Decoupling
Conclusion: MBD4-LOF tumors exhibit a selective, TP53-potentiated pharmacological dependency on ATR kinase inhibition alongside mechanistic vulnerability to cytidine analogs, but lack both the nicked BER repair intermediates and the PARP1 target expression required for single-agent PARP inhibitor efficacy.
PreprintReal-world useRecurrent astrocyte transcriptional states with spatial and functional specialization are induced by brain metastases independently of their primary tumor origin
We identify recurrent tumor-associated astrocyte states shared across tumor origins, map their spatial distribution, and find that a subset, which we term AST-BrM, becomes selectively reprogrammed at the tumor-microenvironment interface, supporting niche-coupled organization rather than a diffuse brain-wide reactive response.
PreprintHDAC1/2 maintain TERT mRNA stability in TERT-rearranged neuroblastoma
We identified histone deacetylases 1 and 2 (HDAC1/2) as essential post-transcriptional guardians of TERT mRNA stability in TERT-rearranged neuroblastoma.
PreprintReal-world useIdentification and isolation of migratory subpopulations of cancer cells using microfluidics with fluid walls
This demonstrates that fluid-walled microfluidics is a versatile and accessible approach for investigating cancer cell migration at single-cell resolution, offering new opportunities to examine cellular heterogeneity in metastasis.
PreprintMERTK and RAC1P29S Drive Melanoma Cannibalism of T cells
An inhibitor screen across RAC1P29S and RAC1WT patient-derived lines showed that cannibalism requires the phosphatidylserine receptor MERTK.
PreprintLoss of CDKN2A remodels Golgi morphology to create a lipid peroxidation vulnerability
Here, we identify altered Golgi morphology as a vulnerability in CDKN2A/p16-Low melanoma.
PreprintSpatial coordination of filamentous enzymes establishes a redox-balancing metabolon
Here, we identify that glutamine deprivation, a common feature of the tumor microenvironment, induces formation of a proline biosynthesis metabolon to selectively maintain intracellular proline levels.
PreprintAneuploidy impairs B cell development but accelerates their MYC-driven transformation
In contrast, BCL2-regulated apoptosis selects viable aneuploid tumor karyotypes in the presence of oncogenic MYC, a notion with implications for the clinical use of BCL2-targeting therapies.
Peer-reviewed journalA molecular glue degrader-antibody conjugate for HER2-targeted cyclin K degradation
These findings demonstrate that antibody-mediated delivery can redistribute the cellular activity of a potent molecular glue degrader towards antigen-positive cells.
PreprintReal-world useSLC25A39 loss disrupts mitochondrial redox homeostasis and exposes therapeutic vulnerabilities in glioblastoma
In this work, we identify SLC25A39 as a metabolic vulnerability and candidate stratification marker in glioblastoma.
PreprintReal-world useDeep Learning Identifies BMI-Associated Morphologic Features in Breast Cancer Tissue
In a cohort of 195 patients with breast cancer, machine learning models using vector embeddings from non-adipose stromal regions classified high BMI ([≥]30 kg/m2) versus low BMI (<25 kg/m2) with an average AUC of 0.78 (95% CI: 0.73-0.83), consistently outperforming models based on tumor-only or combined tumor-stroma regions.
PreprintQuasistable multiclonal carcinomas evolve through mutations with locally extended phenotypes
We found that the acquisition of microenvironmentally extended phenotypes reduces the overall mutational burden of the tissue by increasing the competitiveness of non-mutant cells with cells harbouring cell-autonomous mutations.
PreprintDynamic supercoiling sponsors transcription amplification by MYC
Using a combination of biochemical and cellular assays, we reveal dynamic interplay between MYC-driven transcription amplification and DNA supercoiling.
Peer-reviewed journalTransactivation of EGFR by LCK underlies an activity-defined dependency that predicts response to EGFR inhibition in cholangiocarcinoma
Together, these findings identify a therapeutically actionable LCK-EGFR signaling axis and nominate EGFR activity as a functional biomarker to guide tumor selection for EGFR-directed therapy in CCA, warranting prospective clinical validation.
PreprintBold claims, read criticallyReal-world useCD44-DT regulates p21-dependent senescence via interacting with AR-PCNA complex, revealing a therapeutic vulnerability to chimeric ncRNA-mediated AR degradation in prostate cancer
Thus, the data suggest that CD44-DT is a novel direct AR target gene that modulates PCNA and p21 protein stability identifying a novel negative feed-back loop at the crossroad between proliferation and senescence indicating CD44-DT as a potential therapeutic target for PCa.
PreprintBold claims, read criticallyReal-world useMinor intron splicing restricts E2F transcription factor activity in RB-deregulated prostate cancer
In an in vivo CRISPR screen, we nominate the MiS as the strongest dependency, and U6atac correlates strongest with E2F transcriptional programs in a clinical CRPC cohort.
PreprintReal-world useA marine worm oxygen carrier to improve the quality of preserved tumor samples
Together, these findings suggest that M101 helps preserve structural and functional features of biobanked tumor models during ex vivo handling.
PreprintGATA2 SUMOylation Regulates GATA2 Stability to Control Uterine Serous Carcinoma Invasion
We show that GATA2 in human USC cell lines has a rapid 128-minute protein half-life due to post-translational SUMOylation, which targets GATA2 for ubiquitin-dependent proteasomal degradation.
PreprintReal-world useMidkine and the immunosuppressive tumor microenvironment in pancreatic ductal adenocarcinoma: evidence from Mendelian randomization, multi-omics factor analysis, and single-cell transcriptomics
Collectively, these results support a model in which MDK acts through the stromal-immune compartment rather than through tumor cell-intrinsic mechanisms, and raise the possibility that MDK blockade could restore antitumor immunity in PDAC.
PreprintOptimal combined chemotherapeutic and antibiotic treatment for cancer in the presence of saboteur bacteria
Applying optimal control theory, we explore which combined treatment strategy leads to the best outcome, and how it is influenced by the model parameters.
PreprintReal-world useTargeting Telomere Integrity Enhances Radiosensitivity and Reveals Adaptive DNA Damage Response Vulnerabilities in Diffuse Midline Glioma
Collectively, these findings identify telomere-directed DNA damage as a promising therapeutic approach for DMG and provide a mechanistic rationale for combining THIO with RT and DDR checkpoint inhibition.
PreprintReal-world useFocused ultrasound-enhanced carboplatin delivery improves radiotherapy response and survival in a preclinical glioblastoma model
Results The FUS + carboplatin + RT group demonstrated the strongest therapeutic benefit, compared to all other treatment groups, yielding up to a 122% increase in median survival relative to the untreated group.
PreprintReal-world useERM proteins antagonistically control cancer invasion and metastasis via mechanosensing regulation
Here, we identify the ERM proteins ezrin, radixin, and moesin as key but antagonistic regulators of breast cancer metastasis.
PreprintOvercoming resistance to KRAS inhibition in KRAS/PIK3CA co-mutated colorectal cancer
Together, these findings identify oncogenic PIK3CA as a determinant of resistance to RAS inhibition in KRAS-mutant colorectal cancer and provide a mechanistic rationale for combined KRAS and PI3K inhibition in KRAS/PIK3CA co-mutant tumors.
PreprintReal-world useCombined nelfinavir and cisplatin treatment promotes inflammatory signaling and immunogenic cell death in ovarian cancer cells
Collectively, these findings indicate that NFV enhances the immunogenic consequences of CDDP induced OC cell death, potentially involving cytoplasmic DNA accumulation and STING TBK1 signaling, and promotes protective antitumor immunity in vivo.
PreprintMethylene blue modulates G3BP1-associated condensation and attenuates Kras-driven pancreatic preneoplastic lesions
Together, these findings identify MB as a small-molecule probe that modulates G3BP1 condensation dynamics and demonstrate that chronic MB treatment is associated with the attenuation of early Kras driven pancreatic preneoplastic lesion progression in vivo.
Preprint